BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chaves C, Do TM, Cegarra C, Roudières V, Tolou S, Thill G, Rocher C, Didier M, Lesuisse D. Non-Human Primate Blood-Brain Barrier and In Vitro Brain Endothelium: From Transcriptome to the Establishment of a New Model. Pharmaceutics 2020;12:E967. [PMID: 33066641 DOI: 10.3390/pharmaceutics12100967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gosselet F, Loiola RA, Roig A, Rosell A, Culot M. Central nervous system delivery of molecules across the blood-brain barrier. Neurochem Int 2021;144:104952. [PMID: 33400964 DOI: 10.1016/j.neuint.2020.104952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Cegarra C, Chaves C, Déon C, Do TM, Dumas B, Frenzel A, Kuhn P, Roudieres V, Guillemot JC, Lesuisse D. Exploring ITM2A as a new potential target for brain delivery. Fluids Barriers CNS 2022;19:25. [PMID: 35313913 DOI: 10.1186/s12987-022-00321-3] [Reference Citation Analysis]
3 Salmina AB, Komleva YK, Malinovskaya NA, Morgun AV, Teplyashina EA, Lopatina OL, Gorina YV, Kharitonova EV, Khilazheva ED, Shuvaev AN. Blood-Brain Barrier Breakdown in Stress and Neurodegeneration: Biochemical Mechanisms and New Models for Translational Research. Biochemistry (Mosc) 2021;86:746-60. [PMID: 34225598 DOI: 10.1134/S0006297921060122] [Reference Citation Analysis]
4 Loryan I, Reichel A, Feng B, Bundgaard C, Shaffer C, Kalvass C, Bednarczyk D, Morrison D, Lesuisse D, Hoppe E, Terstappen GC, Fischer H, Di L, Colclough N, Summerfield S, Buckley ST, Maurer TS, Fridén M. Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharm Res. [DOI: 10.1007/s11095-022-03246-6] [Reference Citation Analysis]
5 Cai P, Zheng Y, Sun Y, Zhang C, Zhang Q, Liu Q. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems. ACS Chem Neurosci 2021;12:3829-37. [PMID: 34623131 DOI: 10.1021/acschemneuro.1c00118] [Reference Citation Analysis]
6 Lynch MJ, Gobbo OL. Advances in Non-Animal Testing Approaches towards Accelerated Clinical Translation of Novel Nanotheranostic Therapeutics for Central Nervous System Disorders. Nanomaterials (Basel) 2021;11:2632. [PMID: 34685073 DOI: 10.3390/nano11102632] [Reference Citation Analysis]
7 Watanabe D, Nakagawa S, Morofuji Y, Tóth AE, Vastag M, Aruga J, Niwa M, Deli MA. Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes. Pharmaceutics 2021;13:1484. [PMID: 34575559 DOI: 10.3390/pharmaceutics13091484] [Reference Citation Analysis]